686 Results

People

  1. Giralt
    Giralt
  2. Usmani
    Usmani
  3. Landgren
    Landgren
  4. Lesokhin
    Lesokhin
  5. Landau
    Landau
  6. Mailankody
    Mailankody
  7. Hassoun
    Hassoun
  8. Hultcrantz
    Hultcrantz
  9. Shah
    Shah
  10. Shah
    Shah

Groups

  1. Department of Medicine (425)
  2. Hematologic Malignancies, Division of (378)
  3. Center for Hematologic Malignancies (353)
  4. Myeloma (190)
  5. Hematologic Malignancies Research (156)
  6. Bone Marrow Transplant (145)
  7. Survivorship Research (127)
  8. Sloan Kettering Institute Postdocs (86)
  9. GSK Faculty (76)
  10. Epidemiology and Biostatistics (65)
  1. "multiple myeloma"
Formats
  1. Journal Article (519)
  2. Review (86)
  3. Research Letter (23)
  4. Editorial (17)
  5. Meeting Abstract (15)
  6. Book Section (10)
  7. Correspondence (7)
  8. Guidelines (6)
  9. Conference Paper (2)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (425)
  2. Hematologic Malignancies, Division of (378)
  3. Center for Hematologic Malignancies (353)
  4. Myeloma (190)
  5. Hematologic Malignancies Research (156)
  6. Bone Marrow Transplant (145)

More Groups

People
  1. Sergio Giralt (95)
  2. Saad Usmani (77)
  3. Carl Landgren (76)
  4. Alexander Lesokhin (66)
  5. Heather Landau (55)
  6. Sham Mailankody (55)

More People

Years
  1. 2025 (34)
  2. 2024 (83)
  3. 2023 (85)
  4. 2022 (49)
  5. 2021 (25)
  6. 2020 (47)

More Years

Publications
  1. Blood (37)
  2. Clinical Lymphoma, Myeloma and Leukemia (34)
  3. Biology of Blood and Marrow Transplantation (33)
  4. Leukemia and Lymphoma (21)
  5. Blood Cancer Journal (20)
  6. British Journal of Haematology (20)

More Publications

Publishers
  1. Elsevier Inc. (124)
  2. Nature Publishing Group (84)
  3. American Society of Hematology (48)
  4. Springer (34)
  5. John Wiley & Sons (30)
  6. Taylor & Francis Group (26)

More Publishers

Results (686)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Upfront use of plerixafor and granulocyte-colony stimulating factor (GCSF) for stem cell mobilization in patients with multiple myeloma: Efficacy and analysis of risk factors associated with poor stem cell collection efficiency*
    Journal Article

    Ogunniyi, A.; Rodriguez, M.; Devlin, S.; Adel, N.; Landau, H.; Chung, D. J.; Lendvai, N.; Lesokhin, A.; Koehne, G.; Mailankody, S.; more...
    Leukemia and Lymphoma (2017)

    Fulltext@MSK | Save
  • History of autoimmune disease is associated with impaired survival in multiple myeloma and monoclonal gammopathy of undetermined significance: A population-based study
    Journal Article

    Lindqvist, E. K.; Landgren, O.; Lund, S. H.; Turesson, I.; Hultcrantz, M.; Goldin, L.; Björkholm, M.; Kristinsson, S. Y.
    Annals of Hematology (2017)

    Fulltext@MSK | Save
  • Imaging measurable (minimal) residual disease in multiple myeloma
    Journal Article

    Bhutani, M.; Usmani, S. Z.; Taneja, A.; Landgren, O.
    Current Radiology Reports (2016)

    Fulltext@MSK | Save
  • Cost implications of comorbidity for autologous stem cell transplantation in elderly patients with multiple myeloma using SEER-Medicare
    Journal Article

    Shah, G. L.; Winn, A.; Lin, P. J.; Klein, A.; Sprague, K. A.; Smith, H. P.; Buchsbaum, R.; Cohen, J. T.; Miller, K. B.; Comenzo, R.; more...
    Bone Marrow Research (2016)

    Fulltext@MSK | Save
  • Paraprotein-related kidney disease: Diagnosing and treating monoclonal gammopathy of renal significance
    Journal Article

    Rosner, M. H.; Edeani, A.; Yanagita, M.; Glezerman, I. G.; Leung, N.; for the American Society of Nephrology Onco-Nephrology Forum
    Clinical Journal of the American Society of Nephrology (2016)

    Fulltext@MSK | Save
  • Treatment of high-risk smoldering myeloma
    Journal Article

    Korde, N.
    Seminars in Oncology (2016)

    Fulltext@MSK | Save
  • Recommend upfront consolidation with high-dose melphalan and autologous stem cell support
    Journal Article

    Shah, G. L.; Giralt, S. A.
    Seminars in Oncology (2016)

    Fulltext@MSK | Save
  • The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: Multiple myeloma, lymphoma, and acute leukemia
    Journal Article

    Boyiadzis, M.; Bishop, M. R.; Abonour, R.; Anderson, K. C.; Ansell, S. M.; Avigan, D.; Barbarotta, L.; Barrett, A. J.; Besien, K.; Bergsagel, P. L.; more...
    Journal for ImmunoTherapy of Cancer (2016)

    Fulltext@MSK | Save
  • Myeloid-derived suppressor cells: The green light for myeloma immune escape
    Journal Article

    Malek, E.; de Lima, M.; Letterio, J. J.; Kim, B. G.; Finke, J. H.; Driscoll, J. J.; Giralt, S. A.
    Blood Reviews (2016)

    Fulltext@MSK | Save
  • Single-tube 10-fluorochrome analysis for efficient flow cytometric evaluation of minimal residual disease in plasma cell myeloma
    Journal Article

    Royston, D. J.; Gao, Q.; Nguyen, N.; Maslak, P.; Dogan, A.; Roshal, M.
    American Journal of Clinical Pathology (2016)

    Fulltext@MSK | Save